Atopic dermatitis. Atopic dermatitis, unspecified
Conditions
Interventions
Intervention 1: Patients in the control group should use a drug-free ointment once a day for 8 weeks on lesions.The placebo ointment contains 95% vaseline and 5% bee wax. Intervention 2: Patients in t
Sponsors
Pharmaceutical Sciences branch, Islamic Azad University
Eligibility
Sex/Gender
All
Age
2 Years to 18 Years
Inclusion criteria
Inclusion criteria: aged 2-18 in both genders discontinuation of topical treatment at least 2 weeks ago and for patients who use systemic therapy, it should be stable for months (at least 2 months) and plaque lesions remain in the use of systemic therapy mild to moderate eczema
Exclusion criteria
Exclusion criteria: History of allergy to the compounds in the formulation and vitamin D3 derivatives aged over 18 years Hypervitaminosis D hypercalcemia Patients with acute eczema attack The presence of skin infection or malignancy at the treatment site The presence of diseases associated with vitamin D metabolism disorders
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of Life. Timepoint: beginning of the treatment, 4 weeks and 8 weeks after starting the treatment. Method of measurement: questionnaire.;Eczema severity. Timepoint: beginning of the treatment, 4 weeks and 8 weeks after starting treatment. Method of measurement: EASI. | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse effect. Timepoint: beginning of the treatment, 4 weeks and 8 weeks after starting treatment. Method of measurement: physician assessment. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactRayeheh Tavajjohi
Islamic Azad University Of Pharmaceutical Sciences Branch
Outcome results
None listed